China Therapeutic Vaccines Market (2025-2031) | Share, Segmentation, Growth, Size & Revenue, Forecast, Value, Trends, Industry, Competitive Landscape, Outlook, Analysis, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 China Therapeutic Vaccines Market - Industry Life Cycle

3.4 China Therapeutic Vaccines Market - Porter's Five Forces

3.5 China Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 China Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in China leading to a higher demand for therapeutic vaccines.

4.2.2 Government initiatives to promote vaccination programs and improve healthcare infrastructure.

4.2.3 Growing focus on preventive healthcare measures and a shift towards personalized medicine in the healthcare sector.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines in China.

4.3.2 High research and development costs associated with developing new vaccines.

4.3.3 Limited awareness and acceptance of therapeutic vaccines among the Chinese population.

6.1 China Therapeutic Vaccines Market, By Type

6.1.1 Overview and Analysis

6.1.2 China Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 China Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F

6.1.4 China Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F

6.1.5 China Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F

6.2 China Therapeutic Vaccines Market, By Therapeutic Vaccines

6.2.1 Overview and Analysis

6.2.2 China Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F

6.2.3 China Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F

6.2.4 China Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F

6.2.5 China Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F

6.2.6 China Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F

7.1 China Therapeutic Vaccines Market Export to Major Countries

7.2 China Therapeutic Vaccines Market Imports from Major Countries

8.1 Number of new therapeutic vaccines introduced to the market.

8.2 Percentage increase in vaccination coverage rates in China.

8.3 Research and development investment in therapeutic vaccines.

8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for vaccine development.

8.5 Adoption rate of therapeutic vaccines among healthcare providers and patients in China.

9.1 China Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 China Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F

10.1 China Therapeutic Vaccines Market Revenue Share, By Companies, 2024

10.2 China Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters